Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial.
Puthanakit T, Saphonn V, Ananworanich J, Kosalaraksa P, Hansudewechakul R, Vibol U, Kerr SJ, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Ngo-Giang-Huong N, Chettra K, Cheunyam T, Suwarnlerk T, Ubolyam S, Shearer WT, Paul R, Mofenson LM, Fox L, Law MG, Cooper DA, Phanuphak P, Vun MC, Ruxrungtham K; PREDICT Study Group. Puthanakit T, et al. Among authors: kosalaraksa p. Lancet Infect Dis. 2012 Dec;12(12):933-41. doi: 10.1016/S1473-3099(12)70242-6. Epub 2012 Oct 9. Lancet Infect Dis. 2012. PMID: 23059199 Free PMC article. Clinical Trial.
Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children.
Ananworanich J, Kosalaraksa P, Hill A, Siangphoe U, Bergshoeff A, Pancharoen C, Engchanil C, Ruxrungtham K, Burger D; HIV-NAT 017 Study Team. Ananworanich J, et al. Among authors: kosalaraksa p. Pediatr Infect Dis J. 2005 Oct;24(10):874-9. doi: 10.1097/01.inf.0000180578.38584.da. Pediatr Infect Dis J. 2005. PMID: 16220084 Clinical Trial.
Hospital-based epidemiologic survey of malignancies in children infected with human immunodeficiency virus in Thailand.
Pancharoen C, Nuchprayoon I, Thisyakorn U, Chokephaibulkit K, Veerakul G, Punpanich W, Kanjanapongkul S, Mekmullica J, Wongsawat J, Bowonkiratikachorn P, Hongsiriwon S, Thanarattanakorn P, Kosalaraksa P, Wiangnon S, Saerejittima A, Kochavate S. Pancharoen C, et al. Among authors: kosalaraksa p. Pediatr Infect Dis J. 2005 Oct;24(10):923-4. doi: 10.1097/01.inf.0000180972.63966.35. Pediatr Infect Dis J. 2005. PMID: 16220094
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection.
Ananworanich J, Kosalaraksa P, Siangphoe U, Engchanil C, Pancharoen C, Lumbiganon P, Intasan J, Apateerapong W, Chuenyam T, Ubolyam S, Bunupuradah T, Lange J, Cooper DA, Phanuphak P; HIV-NAT 010 Study Team. Ananworanich J, et al. Among authors: kosalaraksa p. AIDS Res Ther. 2008 Oct 28;5:24. doi: 10.1186/1742-6405-5-24. AIDS Res Ther. 2008. PMID: 18957095 Free PMC article.
Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks.
Bunupuradah T, van der Lugt J, Kosalaraksa P, Engchanil C, Boonrak P, Puthanakit T, Mengthaisong T, Mahanontharit A, Lumbiganon P, Tompkins E, Burger D, Ruxrungtham K, Ananworanich J; HIV-NAT 017 Study Team. Bunupuradah T, et al. Among authors: kosalaraksa p. Antivir Ther. 2009;14(2):241-8. Antivir Ther. 2009. PMID: 19430099
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.
Lallemant M, Ngo-Giang-Huong N, Jourdain G, Traisaithit P, Cressey TR, Collins IJ, Jarupanich T, Sukhumanant T, Achalapong J, Sabsanong P, Chotivanich N, Winiyakul N, Ariyadej S, Kanjanasing A, Ratanakosol J, Hemvuttiphan J, Kengsakul K, Wannapira W, Sittipiyasakul V, Pornkitprasarn W, Liampongsabuddhi P, McIntosh K, Van Dyke RB, Frenkel LM, Koetsawang S, Le Coeur S, Kanchana S; PHPT-4 Study Team. Lallemant M, et al. Clin Infect Dis. 2010 Mar 15;50(6):898-908. doi: 10.1086/650745. Clin Infect Dis. 2010. PMID: 20158398 Free PMC article.
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Puthanakit T, Jourdain G, Hongsiriwon S, Suntarattiwong P, Chokephaibulkit K, Sirisanthana V, Kosalaraksa P, Petdachai W, Hansudewechakul R, Siangphoe U, Suwanlerk T, Ananworanich J; HIV-NAT 086Study Team. Puthanakit T, et al. Among authors: kosalaraksa p. HIV Med. 2010 Oct 1;11(9):565-72. doi: 10.1111/j.1468-1293.2010.00828.x. Epub 2010 Mar 25. HIV Med. 2010. PMID: 20345882 Free article.
154 results